DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20163329

A study on prognostic significance of serum uric acid in acute myocardial infarction in a tertiary care institute

Kaushik Biswas, Subrata Halder, Ramita Sarkar, Koushik Roy

Abstract


Background: This study was done to find out any relationship between serum uric acid and AMI severity and its short-term outcome. To see the correlation between serums uric acid level with Killip Class and mortality outcome following AMI.

Methods: 100 patients of AMI were included this study based on the inclusion and exclusion criteria. Detailed history, physical examination and relevant systemic examination including detailed examination of CVS system were done as per a structured proforma and necessary laboratory investigations were done.

Results: 100 cases of myocardial infarction were studied, out of which 90 patients had STEMI and 10 patients had NSTEMI. There is significant difference of D0 uric acid level was observed for previous history of AMI. There is significant difference in mean uric acid level between dyslipidemic and non-dyslipidemic population. There is significant difference in mean uric acid level on D0 between diabetic and non-diabetic population. Serum uric acid level is low among patients with lower Killip class and high among higher Killip class. Lower the uric acid level, higher the percentage of survival and higher the uric acid level, higher the percentage of mortality.

Conclusions: Patients of Killip class lll and lV had higher levels of uric acid as compared to patients of class l and ll. Combination of Killip class and serum uric acid level after acute myocardial infarction is a good predictor of severity of heart failure after AMI.


Keywords


AMI, Killip class, Uric acid, STEMI, NSTEMI, Dyslipidemia, Diabetes

Full Text:

PDF

References


Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the interheart study): Case-control study. Lancet. 2004;364(9438):937-52.

Anker SD, Doehner W, Rauchhaus M, Sharma R, Francis D, Knosalla C, et al. Uric acid and survival in chronic heart failure: validation and application in metabolic,functional, and hemodynamic staging. Circulation. 2003;107:1991-97.

Leyva F, Anker S, Swan JW, Godsland IF, Wingrove CS, Chua TP, et al. Serum uric acid as an index of impaired oxidative metabolism in chronic heart failure. Eur Heart J. 1997;18:858-65.

A llison TG. Coronary heart disease epidemiology. In: Murphy JG, Lloyd MA, editors. Mayo clinic cardiology. 3rd edition. Rochester (MN): Mayo Clinic Scientific Press. 2007;687-93.

Ochiai ME, Barretto AC, Oliveira MT Jr, Munhoz RT, Morgado PC, Ramires JA. Uric acid renal excretion and renal in sufficiency in decompensated severe heart failure. Eur J Heart Fail. 2005;7:468-74.

Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;21:1685-95.

Kojima S, Sakamoto T, Ishihara M, Kimura K, Miyazaki S, Yamagishi M, et al. Prognostic usefulness of serum uric acid after acute myocardial infarction(Japanese Acute Coronary Syndrome Study).Am J Cardiol. 2005;96:489-95.

Killip T, Kimball JT. Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients. Am J Cardiol. 1967;20:457-64.

Joshi P, Islam S, et al Risk Factors for Early Myocardial Infarction in South Asians Compared With Individuals in Other Countries. JAMA. 2007;297(3):286-94.

Dang A, Dias A. Differences in risk factors and mortality in young and old AMI in Goa. Journal of Clinical and Diagnostic Research. 2008;2:715-9.

Esteghamati A, Abbasi M, Nakhjavani M, Yousefizadeh A, Basa AP, Afshar H. Prevalence of diabetes and other cardiovascular risk factors in an Iranian population with acute coronary syndrome. Cardiovascular Diabetology. 2006;5:15.

Nadkar MY, Jain VI. Serum Uric Acid in Acute Myocardial Infarction. JAPI. 2008;56:759-62.

Sharma LCJ, Kumar BMS. Clinical and angiographic profile of aircrew with coronary heart disease undergoing cardiac evaluation before being reflighted. IJASM. 2002;46(2):32-8.

Jafary MH, Abdus Samad, Ishaq M, awaid SA, Ahmad M, Vohra EA, et al. Profile of AMI in Pakistan. Pak J Med Sci. 2007;23(4):485-9.

Khot UN. Monica B. Khot et al.Prevalence of Conventional Risk Factors in Patients With Coronary Heart Disease. JAMA. 2003;290(7):898-904.

Safi AJ, Mahmood R, Khan MA. Association of serum Uric Acid with type II diabetes mellitus. J Postgrad Med Inst. 2004;18:59-63.

Wu YQ , Li J, Xu YX, Wang YL, Luo YY, Hu DY, et al. Predictive value of serum uric acid on cardiovascular disease and all-cause mortality in urban Chinese patients. Chinese Med J. 2010;123(11):1387-91.

Conen D, Wietlisbach V, Bovet P, Shamlaye C, Riesen W, Paccaud F, et al. Prevalence of hyperuricemia and relation of serum uric acid with cardiovascular risk factors in a developing country. BMC Public Health. 2004;4:9.